| Title |
IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders
|
|---|---|
| Published in |
SpringerPlus, July 2015
|
| DOI | 10.1186/s40064-015-1137-x |
| Pubmed ID | |
| Authors |
Giorgio Calisti, Amanda Tavares, Malcolm J Macartney, Adele McCormick, Wendy Labbett, Michael Jacobs, Geoffrey Dusheiko, William M Rosenberg, Tanzina Haque |
Mendeley readers
The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 14 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 3 | 21% |
| Professor | 2 | 14% |
| Other | 1 | 7% |
| Student > Bachelor | 1 | 7% |
| Student > Ph. D. Student | 1 | 7% |
| Other | 2 | 14% |
| Unknown | 4 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 43% |
| Agricultural and Biological Sciences | 2 | 14% |
| Biochemistry, Genetics and Molecular Biology | 2 | 14% |
| Unknown | 4 | 29% |